KDR and breast carcinoma: In continuation to our research, which deals with the discovery of novel potent anticancer agents [23,24,25,26,27,28], herein we utilized the fragment linking strategy to construct novel anti-proliferative agents for MCF-7 breast cancer therapy and evaluated their effectiveness on VEGFR enzyme inhibition.